{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T20:33:54Z","timestamp":1718483634853},"reference-count":29,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Novartis vaccines"},{"name":"NIHR Oxford Comprehensive Biomedical Research Centre"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.vaccine.2013.03.036","type":"journal-article","created":{"date-parts":[[2013,4,6]],"date-time":"2013-04-06T03:23:07Z","timestamp":1365218587000},"page":"2441-2448","source":"Crossref","is-referenced-by-count":16,"title":["The B-cell response to a primary and booster course of MenACWY-CRM197 vaccine administered at 2, 4 and 12 months of age"],"prefix":"10.1016","volume":"31","author":[{"given":"Geraldine","family":"Blanchard-Rohner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew D.","family":"Snape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic F.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"O\u2019Connor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tessa","family":"John","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Clutterbuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Ohene-Kena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaam L.","family":"Klinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Odrljin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew J.","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.03.036_bib0005","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/INF.0b013e31818e037d","article-title":"Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants","volume":"28","author":"Perrett","year":"2009","journal-title":"Pediatric Infect Dis J"},{"issue":"January (2)","key":"10.1016\/j.vaccine.2013.03.036_bib0010","first-page":"173","article-title":"Immunogenicity of a tetravalent meningococcal glycoconjugate vaccine in infants: a randomized controlled trial","volume":"299","author":"Snape","year":"2008","journal-title":"JAMA"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.03.036_bib0015","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1084\/jem.129.6.1307","article-title":"Human immunity to the meningococcus. I. The role of humoral antibodies","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2013.03.036_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.4049\/jimmunol.24.4.273","article-title":"Influenzal meningitidis: the relation of age incidence to the bactericidal power of blood against causal organism","volume":"24","author":"Fothergill","year":"1933","journal-title":"J Immunol"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2013.03.036_bib0025","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1093\/intimm\/10.11.1703","article-title":"Survival of long-lived plasma cells is independent of antigen","volume":"10","author":"Manz","year":"1998","journal-title":"Int Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.03.036_bib0030","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/eji.1830260226","article-title":"The phenotype and fate of the antibody-forming cells of the splenic foci","volume":"26","author":"Smith","year":"1996","journal-title":"Eur J Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.03.036_bib0035","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1074-7613(00)80541-5","article-title":"Humoral immunity due to long-lived plasma cells","volume":"8","author":"Slifka","year":"1998","journal-title":"Immunity"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2013.03.036_bib0040","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/CDLI.4.2.156-167.1997","article-title":"Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group","volume":"4","author":"Maslanka","year":"1997","journal-title":"Clin Diagn Lab Immunol"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.03.036_bib0045","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"issue":"June (6)","key":"10.1016\/j.vaccine.2013.03.036_bib0050","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"issue":"July (9431)","key":"10.1016\/j.vaccine.2013.03.036_bib0055","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"issue":"June (21)","key":"10.1016\/j.vaccine.2013.03.036_bib0060","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1001\/jama.283.21.2795","article-title":"Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial","volume":"283","author":"MacLennan","year":"2000","journal-title":"JAMA"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.03.036_bib0065","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.inf.0000151029.58752.27","article-title":"Lack of serum bactericidal activity in preschool children two years after a single dose of serogroup C meningococcal polysaccharide-protein conjugate vaccine","volume":"24","author":"Snape","year":"2005","journal-title":"Pediatric Infect Dis J"},{"issue":"February (4)","key":"10.1016\/j.vaccine.2013.03.036_bib0070","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.4049\/jimmunol.180.4.2165","article-title":"The magnitude of the antibody and memory B cell responses during priming with a protein-polysaccharide conjugate vaccine in human infants is associated with the persistence of antibody and the intensity of booster response","volume":"180","author":"Blanchard Rohner","year":"2008","journal-title":"J Immunol"},{"issue":"January (3)","key":"10.1016\/j.vaccine.2013.03.036_bib0075","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.vaccine.2009.10.104","article-title":"Immunogenicity and tolerability of a quadrivalent meningococcal glycoconjugate vaccine in children 2\u201310 years of age","volume":"28","author":"Black","year":"2010","journal-title":"Vaccine"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.03.036_bib0080","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1128\/CVI.00384-09","article-title":"Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vaccine","volume":"17","author":"Borrow","year":"2010","journal-title":"Clin Vaccine Immunol"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2013.03.036_bib0085","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/eji.1830180221","article-title":"The half-lives of serum immunoglobulins in adult mice","volume":"18","author":"Vieira","year":"1988","journal-title":"Eur J Immunol"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2013.03.036_bib0090","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.4049\/jimmunol.170.6.2824","article-title":"Unresponsiveness to lymphoid-mediated signals at the neonatal follicular dendritic cell precursor level contributes to delayed germinal center induction and limitations of neonatal antibody responses to T-dependent antigens","volume":"170","author":"Pihlgren","year":"2003","journal-title":"J Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.03.036_bib0095","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0167-5699(99)01548-0","article-title":"Neonatal immunity: how well has it grown up?","volume":"21","author":"Marshall-Clarke","year":"2000","journal-title":"Immunol Today"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.03.036_bib0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1002\/1521-4141(200103)31:3<939::AID-IMMU939>3.0.CO;2-I","article-title":"Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life","volume":"31","author":"Pihlgren","year":"2001","journal-title":"Eur J Immunol"},{"issue":"October (8)","key":"10.1016\/j.vaccine.2013.03.036_bib0105","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.4049\/jimmunol.157.8.3357","article-title":"The xid mutation diminishes memory B cell generation but does not affect somatic hypermutation and selection","volume":"157","author":"Ridderstad","year":"1996","journal-title":"J Immunol"},{"issue":"May (1)","key":"10.1016\/j.vaccine.2013.03.036_bib0110","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2567.2008.02934.x","article-title":"Plasma and memory B-cell kinetics in infants following a primary schedule of CRM 197-conjugated serogroup C meningococcal polysaccharide vaccine","volume":"127","author":"Kelly","year":"2009","journal-title":"Immunology"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.03.036_bib0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10096-009-0848-8","article-title":"Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers","volume":"29","author":"Halperin","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.03.036_bib0120","first-page":"185","article-title":"B-cell responses to vaccination at the extremes of age","volume":"9","author":"Siegrist","year":"2009","journal-title":"Nat Rev"},{"key":"10.1016\/j.vaccine.2013.03.036_bib0125","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2006-01-009282","article-title":"CRM197-conjugated serogroup C meningococcal capsular polysaccharide, but not the native polysaccharide, induces persistent antigen specific memory B cells","author":"Kelly","year":"2006","journal-title":"Blood"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2013.03.036_bib0130","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/INF.0b013e318262528c","article-title":"Persistence of antibody response following a booster dose of Hib-MenC-TT glycoconjugate vaccine to five years: a follow-up study","volume":"31","author":"Khatami","year":"2012","journal-title":"Pediatric Infect Dis J"},{"issue":"12","key":"10.1016\/j.vaccine.2013.03.036_bib0135","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1086\/652765","article-title":"Antibody persistence after serogroup C meningococcal conjugate immunization of United Kingdom primary-school children in 1999\u20132000 and response to a booster: a phase 4 clinical trial","volume":"50","author":"Perrett","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.03.036_bib0140","unstructured":"Department of Health. Joint Committee on Vaccination and Immunisation MotmoWOL. Joint Committee on Vaccination and Immunisation, Minute of the meeting on Wednesday 3 October 2012 London; 2012."},{"issue":"March (3)","key":"10.1016\/j.vaccine.2013.03.036_bib0145","first-page":"213","article-title":"Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines","volume":"9","author":"Pollard","year":"2009","journal-title":"Nat Rev"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1300371X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1300371X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T11:50:18Z","timestamp":1715169018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1300371X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":29,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0264410X1300371X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.03.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}